People who are pregnant or breastfeeding, who have active cancer, or who have certain medical conditions should generally avoid it unless a qualified clinician advises otherwise
By protecting nitric oxide from free radicals
References Sun X, Deng Y, Fu X, Wang S, Duan R, Zhang Y
BPC-157 has been studied primarily in preclinical and experimental settings, where it has demonstrated potential benefits in accelerating wound healing, improving gut integrity, and supporting joint and soft tissue health
2A,B 100%)
Research suggests that patients who maintain GLP-1 therapy for 12+ months experience slower, more gradual regain after stopping compared to those who use it for only a few weeks